• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期肾病患者中男性和女性缺血性心脏病的发病率:一项队列研究。

Incidence of Ischaemic Heart Disease in Men and Women With End-Stage Kidney Disease: A Cohort Study.

机构信息

Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia; Centre for Kidney Research, Children's Hospital at Westmead, Sydney, NSW, Australia.

Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.

出版信息

Heart Lung Circ. 2020 Oct;29(10):1517-1526. doi: 10.1016/j.hlc.2020.03.002. Epub 2020 Mar 23.

DOI:10.1016/j.hlc.2020.03.002
PMID:32253129
Abstract

BACKGROUND

The incidence of ischaemic heart disease (IHD) has fallen consistently in the general population; attributed to effective primary prevention strategies. Differences in incidence have been demonstrated by sex. Whether this fall in incidence and sex differences is mirrored in people with end-stage kidney disease (ESKD) is unclear. We aimed to establish the relative risk of IHD events in the ESKD population.

METHODS

We performed a retrospective cohort study from 2000 to 2010 in people with ESKD in New South Wales. We performed data linkage of the Australia and New Zealand Dialysis and Transplant Registry and state wide hospital admission and death registry data and compared this to general population data. The primary outcome was the incidence rate, incidence rate ratio (IRR), and time-trend for any IHD event. We calculated these using indirect standardisation by IHD event.

RESULTS

10,766 participants, contributed 44,149 years of observation time. Incidence rates were substantially higher than the general population for all IHD events (any IHD event: IRR 1.8, 95% confidence interval [CI] 1.7-1.9 for men, IRR 3.4, 95% CI 3.1-3.6 for women). Excess risk was higher in younger people (age 30-49 IRR 4.8, 95% CI 4.2-5.4), and in women with a three-fold increase risk overall and nearly a 10-fold increase in risk in young women (female age 30-49 years: IRR 9.8 95% CI 7.7-12.3), results were similar for angina and acute myocardial infarction. Ischaemic heart disease rates showed some decline for men over time, (ratio of IRR 0.93, 95% CI 0.90-0.95) but were stable for women (ratio of IRR 0.97, 95% CI 0.94-1.01).

CONCLUSIONS

People with ESKD have substantially higher rates of IHD than the general population, especially women, in whom no improvement appears evident over the past 10 years.

摘要

背景

缺血性心脏病(IHD)的发病率在普通人群中持续下降;归因于有效的初级预防策略。不同性别之间的发病率存在差异。在终末期肾病(ESKD)患者中,这种发病率的下降和性别差异是否得到体现尚不清楚。我们旨在确定 ESKD 人群中 IHD 事件的相对风险。

方法

我们在 2000 年至 2010 年间对新南威尔士州的 ESKD 患者进行了回顾性队列研究。我们对澳大利亚和新西兰透析和移植登记处以及全州住院和死亡登记处的数据进行了数据链接,并将其与普通人群的数据进行了比较。主要结局是任何 IHD 事件的发生率、发病率比(IRR)和时间趋势。我们使用 IHD 事件的间接标准化来计算这些。

结果

10766 名参与者,贡献了 44149 年的观察时间。与普通人群相比,所有 IHD 事件的发生率都明显较高(任何 IHD 事件:男性 IRR 为 1.8,95%置信区间[CI]为 1.7-1.9,女性 IRR 为 3.4,95%CI 为 3.1-3.6)。年轻人的风险更高(年龄 30-49 岁 IRR 为 4.8,95%CI 为 4.2-5.4),女性总体风险增加三倍,年轻女性风险增加近十倍(女性年龄 30-49 岁:IRR 9.8,95%CI 为 7.7-12.3),心绞痛和急性心肌梗死的结果相似。随着时间的推移,男性的 IHD 发病率有所下降(IRR 的比值为 0.93,95%CI 为 0.90-0.95),而女性则保持稳定(IRR 的比值为 0.97,95%CI 为 0.94-1.01)。

结论

与普通人群相比,ESKD 患者的 IHD 发生率明显较高,尤其是女性,在过去 10 年中,女性的 IHD 发病率似乎没有明显改善。

相似文献

1
Incidence of Ischaemic Heart Disease in Men and Women With End-Stage Kidney Disease: A Cohort Study.终末期肾病患者中男性和女性缺血性心脏病的发病率:一项队列研究。
Heart Lung Circ. 2020 Oct;29(10):1517-1526. doi: 10.1016/j.hlc.2020.03.002. Epub 2020 Mar 23.
2
Absolute risk and risk factors for stroke mortality in patients with end-stage kidney disease (ESKD): population-based cohort study using data linkage.终末期肾病(ESKD)患者中风死亡率的绝对风险和风险因素:基于人群的队列研究,使用数据链接。
BMJ Open. 2019 Feb 22;9(2):e026263. doi: 10.1136/bmjopen-2018-026263.
3
First and recurrent ischaemic heart disease events continue to decline in New Zealand, 2005-2015.2005年至2015年期间,新西兰首次发生及复发性缺血性心脏病事件持续减少。
Heart. 2018 Jan;104(1):51-57. doi: 10.1136/heartjnl-2017-311613. Epub 2017 Jun 29.
4
Risk Factors for Stroke in People with End-Stage Kidney Disease: A Cohort Study.终末期肾病患者中风的危险因素:一项队列研究
Cerebrovasc Dis. 2016;42(5-6):428-438. doi: 10.1159/000445067. Epub 2016 Aug 10.
5
Risk of Stroke in Patients with ESRD.终末期肾病患者的中风风险
Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1585-92. doi: 10.2215/CJN.12001214. Epub 2015 Jul 24.
6
Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study.强直性脊柱炎与缺血性心脏病风险:基于人群的队列研究。
Ann Rheum Dis. 2016 Jan;75(1):203-9. doi: 10.1136/annrheumdis-2014-206147. Epub 2014 Oct 31.
7
Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013.澳大利亚 1 型和 2 型糖尿病患者终末期肾病发病率趋势,2002-2013 年。
Am J Kidney Dis. 2019 Mar;73(3):300-308. doi: 10.1053/j.ajkd.2018.10.005. Epub 2018 Dec 19.
8
Both incidence and prevalence of ischaemic heart disease are declining in parallel: a national data-linkage study in New Zealand (ANZACS-QI 52).在新西兰进行的一项全国数据链接研究(ANZACS-QI 52)表明,缺血性心脏病的发病率和患病率都在同步下降。
Eur J Prev Cardiol. 2022 Mar 11;29(2):321-327. doi: 10.1093/eurjpc/zwaa120.
9
Death From Stroke in End-Stage Kidney Disease.终末期肾病的中风死亡。
Stroke. 2019 Feb;50(2):487-490. doi: 10.1161/STROKEAHA.118.023644.
10
Changes in excess mortality among adults with diabetes-related end-stage kidney disease: a comparison between the USA and Australia.糖尿病相关终末期肾病成人患者超额死亡率的变化:美国与澳大利亚的比较。
Nephrol Dial Transplant. 2022 Sep 22;37(10):2004-2013. doi: 10.1093/ndt/gfab315.

引用本文的文献

1
Kidney replacement therapy: trends in incidence, treatment, and outcomes of myocardial infarction and stroke in a nationwide Scottish study.肾脏替代疗法:一项全国性苏格兰研究中,心肌梗死和中风的发病率、治疗和结局趋势。
Eur Heart J. 2024 Apr 14;45(15):1339-1351. doi: 10.1093/eurheartj/ehae080.
2
Hemodialysis Vascular Access and Risk of Major Bleeding, Thrombosis, and Cardiovascular Events: A Cohort Study.血液透析血管通路与大出血、血栓形成及心血管事件风险:一项队列研究
Kidney Med. 2022 Mar 24;4(6):100456. doi: 10.1016/j.xkme.2022.100456. eCollection 2022 Jun.